Edwin Lawrence Jacobs, MD | |
181 S Buena Vista St, 4rth Floor, Burbank, CA 91505-4504 | |
(818) 840-0921 | |
(818) 840-7064 |
Full Name | Edwin Lawrence Jacobs |
---|---|
Gender | Male |
Speciality | Hematology/oncology |
Experience | 39 Years |
Location | 181 S Buena Vista St, Burbank, California |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1366462939 | NPI | - | NPPES |
OOG628130 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RH0003X | Internal Medicine - Hematology & Oncology | G62813 (California) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Providence Saint Joseph Medical Ctr | Burbank, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Providence Medical Institute | 5991609737 | 290 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
All walk to school routes in Wales should be designated 20 mph zones, according to Welsh doctors leaders.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
"An analysis of 30,000-year-old bacteria whose DNA has been recovered from the Yukon permafrost shows that they were able to resist antibiotics," providing "the first direct evidence that antibiotic resistance is a widespread natural phenomenon that preceded the modern medical use of antibiotics," according to a study in Thursday's issue of the journal Nature, the New York Times reports.
› Verified 7 days ago
Entity Name | Providence Medical Institute |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417915760 PECOS PAC ID: 5991609737 Enrollment ID: O20031121000910 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
All walk to school routes in Wales should be designated 20 mph zones, according to Welsh doctors leaders.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
"An analysis of 30,000-year-old bacteria whose DNA has been recovered from the Yukon permafrost shows that they were able to resist antibiotics," providing "the first direct evidence that antibiotic resistance is a widespread natural phenomenon that preceded the modern medical use of antibiotics," according to a study in Thursday's issue of the journal Nature, the New York Times reports.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Edwin Lawrence Jacobs, MD Po Box 51194, Los Angeles, CA 90051-5494 Ph: (818) 840-0921 | Edwin Lawrence Jacobs, MD 181 S Buena Vista St, 4rth Floor, Burbank, CA 91505-4504 Ph: (818) 840-0921 |
News Archive
A new international study for women with HER2-positive breast cancer is open for enrollment. The pivotal BETH (BEvacizumab and Trastuzumab Adjuvant Therapy in HER2-positive Breast Cancer) study is a Phase III clinical research trial that is investigating the benefits of combining two monoclonal antibodies, the anti-angiogenic, bevacizumab (Avastin) and the targeted therapy trastuzumab (Herceptin), together with chemotherapy for the treatment of patients with early stage HER2-positive breast cancer.
All walk to school routes in Wales should be designated 20 mph zones, according to Welsh doctors leaders.
PlanSource, a cloud-based, on-demand technology company that provides state-of-the-art benefits administration, exchange, payroll, and HRIS solutions to employers through insurance carriers and brokers, has announced that it is expanding its strategic relationship with Aetna into three new states: Georgia, North Carolina, and Tennessee.
"An analysis of 30,000-year-old bacteria whose DNA has been recovered from the Yukon permafrost shows that they were able to resist antibiotics," providing "the first direct evidence that antibiotic resistance is a widespread natural phenomenon that preceded the modern medical use of antibiotics," according to a study in Thursday's issue of the journal Nature, the New York Times reports.
› Verified 7 days ago
Boris Arbit, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2625 W Alameda Ave Ste 322, Burbank, CA 91505 Phone: 818-843-9015 Fax: 818-843-9016 | |
Dr. Daniel Kwan Dea, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2701 W Alameda Ave, Suite 601, Burbank, CA 91505 Phone: 818-846-2766 Fax: 818-556-4170 | |
Dr. Abigail Maller, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2625 W Alameda Ave Ste 322, Burbank, CA 91505 Phone: 818-843-9015 Fax: 818-843-9016 | |
Dr. Mark A Gerard, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 201 S Buena Vista St, Suite # 250, Burbank, CA 91505 Phone: 818-562-3200 Fax: 818-562-3205 | |
Jamileh Hanna, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2550 N Hollywood Way Ste 100, Burbank, CA 91505 Phone: 818-524-3730 Fax: 818-847-8675 | |
Dr. Cecelia Theresa Madrid, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2701 W Alameda Ave Ste 500, Burbank, CA 91505 Phone: 818-567-6550 Fax: 818-558-4379 | |
Grace I Wong, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3808 W Riverside Dr Ste 201, Burbank, CA 91505 Phone: 818-563-1449 Fax: 818-563-1049 |